Issue
Title
Authors
Vol 29, No 2 (2021)
The methodology of controllable medical pharmaceutical monitoring of patients: from theory to practice (publications review)
Kirshcina I.A., Soloninina A.V., Krasheninnirov A.E., Khabriev R.U.
Vol 32, No 2 (2024)
The interdisciplinary approach as tool of pharmaceutical education of children: from theory to practice
Kuryleva M.A., Kirshchina I.A., Soloninina A.V., Michkailova V.N., Krasheninnikov A.E.
PDF
(Rus)
Vol 30, No 6 (2022)
The Renaissance of Russian pharmaceutical market (2000-2004). Report I. The field players
Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
PDF
(Rus)
Vol 32, No 4 (2024)
The development of regulation of pharmaceuticals turn-over in EU and the USA in 1992–2020. Report 2. Development of normative legal base of pharmaceuticals turn-over in EU in 1992–2001
Volskaya E.A.
PDF
(Rus)
Vol 31, No 1 (2023)
The Renaissance of Russian pharmaceutical market (2000-2004). Report II. The Pharma servants of Russia
Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
PDF
(Rus)
Vol 30, No 5 (2022)
The 1998 default and the pharmaceutical market. Report 2: Predictions and Estimates
Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
PDF
(Rus)
Vol 30, No 4 (2022)
The default of 1998 and pharmaceutical market. Report I. The chronicle of disaster
Zatravkin S.N., Ignatiev V.G., Vishlenkova E.A.
PDF
(Rus)
Vol 30, No 3 (2022)
The Russian pharmaceutical industry in 1990s. Report III. Insider vision
Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
Vol 32, No 5 (2024)
The development of regulation of pharmaceuticals turn-over in EU and the USA in 1992–2020. Report 3. The making of the EU legislation of pharmaceuticals turn-over in 2001–2020
Volskaya E.A.
PDF
(Rus)
Vol 30, No 2 (2022)
The Russian pharmaceutical branch in 1990s. Report II. The optics of external observers
Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
PDF
(Rus)
Vol 30, No 2 (2022)
The Russian pharmaceutical market: the main trends of development and pricing in modern conditions
Botnaryuk M.V., Timchenko T.N.
Vol 32, No 3 (2024)
The long 1992 in medicinal (non-)security of Russia. Report II. Market networks and institutes
Ignatiev V.G., Zatravkin S.N., Vishlenkova E.A.
PDF
(Rus)
Vol 30, No 1 (2022)
The Russian pharmaceutical branch in 1990s. Report 1. From the Soviet to the market
Zatravkin S.N., Vishlenkova E.A., Ignatiev V.G.
Vol 32, No 3 (2024)
On the issue of logistic support of export of medicinal preparations of national production
Konfino K.V.
PDF
(Rus)
Vol 29, No 3 (2021)
The analysis and assessment of problems of medicinal support in The Russian Federation in actual conditions
Telnova E.A.
Vol 32, No 2 (2024)
The long 1992 year in medicinal (non-)security of Russia. Report I. Market trial
Ignatiev V.G., Zatravkin S.N., Vishlenkova E.A.
PDF
(Rus)
Vol 27, No 5 (2019)
The characteristics of regulation of pharmaceutical market of the Eurasian Economical Union
Marseva T.G., Voblaia I.N., Seifieva E.N.
1 - 17 of 17 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Mailing Address

Address: 105064, Vorontsovo Pole, 12, Moscow

Email: ttcheglova@gmail.com

Phone: +7 903 671-67-12

Principal Contact

Tatyana Sheglova
Head of the editorial office
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Phone: +7 903 671-67-12
Email: redactor@journal-nriph.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies